- Home
- CHPT vs ONCY Comparison
CHPT vs ONCY Comparison
Compare CHPT & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHPT | ONCY |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.6M | 107.3M |
| IPO Year | 2019 | 2002 |
Fundamental Metrics
Financial Performance| Metric | CHPT | ONCY |
|---|---|---|
| Price | $5.39 | $0.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $9.25 | $7.33 |
| AVG Volume (30 Days) | 480.6K | ★ 1.5M |
| Earning Date | 06-03-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $411,224,000.00 | N/A |
| Revenue This Year | $4.18 | N/A |
| Revenue Next Year | $16.63 | $2,505.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.44 | $0.73 |
| 52 Week High | $12.62 | $1.51 |
Technical Indicators
Market Signals| Indicator | CHPT | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 46.38 | 37.89 |
| Support Level | $5.10 | N/A |
| Resistance Level | $6.61 | $1.06 |
| Average True Range (ATR) | 0.33 | 0.04 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 34.65 | 15.14 |
Price Performance
Historical ComparisonAbout CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable charging systems owners, charge point operators, to manage their Networked Charging Systems, and to enable drivers to locate, reserve and authenticate Networked Charging Systems and to transact EV charging sessions on those systems. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. The company derives the majority of its revenue from the United States.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.